Yahoo Search Búsqueda en la Web

Entrar

Resultado de búsqueda

  1. www.nejm.org › doi › fullAsthma in Adults | NEJM - New England Journal of Medicine

    8 de sept. de 2023 · Asthma is characterized by recurring symptoms, airflow obstruction, bronchial hyperresponsiveness, and underlying inflammation. A stepped approach to symptom control and reduction of...

  2. www.nejm.org › doi › fullBiologic Therapies for Severe Asthma | NEJM

    12 de ene. de 2022 · Biologic agents are efficacious add-on therapies for uncontrolled, severe eosinophilic asthma. These therapies represent major breakthroughs, significantly decreasing exacerbation rates and ...

  3. www.nejm.org › doi › fullAsthma in Adults | New England Journal of Medicine

    29 de nov. de 2023 · To the Editor: To bring focus to discrepancies in asthma-related incidence, morbidity, and mortality falling along socioeconomic lines, the inequity in the availability of guideline-concordant...

  4. pubmed.ncbi.nlm.nih.gov › 35020986Biologic Therapies for Severe Asthma - PubMed

    13 de ene. de 2022 · Biologic Therapies for Severe Asthma. N Engl J Med. 2022 Jan 13;386 (2):157-171. doi: 10.1056/NEJMra2032506. Authors. Guy G Brusselle 1 , Gerard H Koppelman 1. Affiliation.

  5. evidence.nejm.org › doi › fullTezepelumab and Mucus Plugs in Patients with Moderate-to ...

    20 de sept. de 2023 · This analysis of the CASCADE (Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma) placebo-controlled trial used computed tomography (CT) imaging to assess...

  6. resident360.nejm.org › clinical-pearls › biologicBiologic Therapies for Severe Asthma | NEJM Resident 360

    12 de ene. de 2022 · Patients with severe asthma are at increased risk for a decreased quality of life, fixed airway obstruction, hospitalization, and death. Biologics may be required to reduce the disease burden....

  7. resident360.nejm.org › content-items › asthma-in-adultsAsthma in Adults | NEJM Resident 360

    13 de sept. de 2023 · Asthma is characterized by recurring symptoms, airflow obstruction, bronchial hyperresponsiveness, and underlying inflammation. A stepped approach to symptom control and reduction of...